Sera Die CD 2.0
Egal ob professionelles Koifutter, Futter für Goldfische oder spezielles Futter für Sterlets - die sera Teichfutter sind optimal an die Ernährungsgewohnheiten der jeweiligen Teichbewohner angepasst und unterstützen gleichzeitig deren Immunsystem. Hier finden Sie das richtige Futter für gesunde Teichfische ...
sera Die CD 2.0
Teichpflege mit System. sera systematisiert die Teichpflege anhand von häufig auftretenden Problemstellungen. Hier finden Sie die richtigen Produkte, um systematisch für eine optimale Wasserqualität in Ihrem Teich zu sorgen.
Um Aquaristik-Neulingen den Einstieg in das beliebte Hobby zu erleichtern, hat sera eine umfangreiche Software entwickelt. Auf der neuen CD finden Interessierte einen großen Ratgeber-Bereich zur Einrichtung und Pflege sowie Vorschläge und Empfehlungen für Biotope.
Nach eigenen Wünschen kann der Benutzer außerdem sein individuelles Aquarium zusammenstellen. Ergebnis: Eine dreidimensionale Vorschau sowie eine Einkaufsliste, mit der im Fachhandel alle erforderlichen sera Produkte besorgt werden können.
Der neue sera Aquarienplaner ist in vier wesentliche Kategorien aufgeteilt, die sich über Updates immer weiter ausbauen lassen: Im Ratgeberbereich werden grundlegende Fragen geklärt sowie das Einrichten und Pflegen des Aquariums erläutert. Zusätzlich beinhaltet das Aquaristik-Lexikon detaillierte Informationen zu 130 Fischen und 60 Pflanzen.
What accounts for the ability of omicron to infect those who have been previously vaccinated? Molecular studies show that both major Omicron sublineages, BA.1 and BA.2, are heavily mutated in the Spike protein, both in the gene's S1 and S2 subunit portions. These mutations dramatically alter the ability of both convalescent sera and monoclonal antibodies to recognize, bind, and neutralize the Omicron variants. Although BA.1 and BA.2 share many common mutations in the Spike protein, there are several differences. Of the 42 distinct mutations found in the BA.1 and BA.2 sublineages, 21 are shared, while 13 are exclusive to BA.1 and eight are exclusive to BA.2.
It seems likely that both BA.1 and BA.2 are similar concerning their diminished sensitivity to neutralizing antibodies from vaccines, monoclonal treatments, or convalescent sera, perhaps accounting for the variant's rapid spread. A thoroughly-vaccinated population such as Denmark and Israel seem to be highly susceptible to infection by Omicron as a consequence.
Will Omicron infection provide robust protection against other infections? If current vaccines do not provide reasonable protection against Omicron, will Omicron-specific vaccines provide good protection against previous and new variants to come? The answer is not necessarily yes. Although existing data shows that Omicron infection will protect against reinfection, Omicron sera poorly neutralizes other variants. A simple conclusion would be that Omicron infection is unlikely to protect against future variants to come.
The binding of HA mini-stem to the pan-influenza bnAb, FI6v3 (Table S1, Figure S2) and the potential for developing a broadly reactive antibody response by our vaccine motivated us to test the sera against influenza A group 2 HAs (H3/H7). Encouragingly, the Abs elicited by the designed immunogens also bound H3 and H7 HAs with modest affinity and low-level binding to influenza B HA (Fig. 2C-E). Antibodies elicited by the HA mini-stem compete with the bnAb CR6261 for binding to H1N1 (pdm Ca/09) HA (Fig. 2D), therefore they may also inhibit virus replication by targeting the stem region.
A yeast surface display (YSD) library expressing HA fragments of heterologous influenza A H1 HA (pdm Ca/09) and H3 HA (HK/68) were used to determine whether these mini-stem can induce antibodies that are specific to the HA2 stem region (Figure S5). The HA mini-stem vaccine serum showed higher-level H1-YSD library binding than H1N1 (pdm Ca/09) convalescent sera (Figure S5A). The binding of HA mini-stem vaccine serum for the H3-YSD library was also higher than H1N1 (pdm Ca/09) convalescent sera, which had no detectable binding (Figure S5D). Sequencing of HA-YSD clones bound by H1F and H5F serum indicated an immunodominant antibody response towards the HA stem (Figure S5H), therefore our vaccine successfully stimulates stem-specific antibodies.
We also hypothesize that subtle differences between the neutralization epitopes of the HA stem among different viral subtypes may explain the disparate neutralization efficacy of the HA mini-stem polyclonal sera against the tested viruses. H5F and H1F vaccination induced a polyclonal Ab response which bind multiple epitopes within the HA-stem, resulting in H1N1, H3N2 and H7N7 virus neutralization, whilst these same epitopes may not be present in H5 viruses. Thus, protection from HPAI H5N1 infection by vaccine serum (Fig. 3D), may use an alternate immune mechanism which is yet to be determined. Further study on the modes of protection of these stem-specific antibodies will be needed.
The HA mini-stem elicits high affinity, stem-specific antibodies with protective potential. Further immune sera characterization revealed that vaccination with Addavax does not skew the balance of the natural Ab response, as the IgG1/IgG2a ratio (which reflects the Th1/Th2 balance) is similar to convalescent H3N2 (HK/68) sera (Figure S7A). The IgA and IgM levels in the sera are comparable to those in unvaccinated mice (Figure S7B,C). Vaccination also results in a broadly binding early antibody response from day 7 after H3N2 infection, which is otherwise undetectable in unvaccinated mice (Figure S7D) and the response is maintained to at least day 28-post challenge (Figure S7E). Furthermore, the magnitude and avidity of vaccine (H5F and H5) and cross-reactive (H3) Ab response remained relatively unchanged over time (Figure S7F,H) up to 120 days post vaccination.
There have been some concerns over antibody dependent enhancement (ADE) for stem-specific antibodies, resulting in increased influenza infection of vaccinated animals32. Whilst no increase in lung viral loads was observed in vaccinated mice (Fig. 3), to ensure our vaccine did not increase influenza virus entry, an in vitro infection in the presence of immune sera was performed (Fig. 4C). Raji cell infection rate in the presence of naïve mouse sera was 20%, whilst H1N1 convalescent sera had a 1.5% infection rate, an impressive 13-fold reduction. Whilst H1FS had a modest 15.4% H1N1 infection rate (1.3-fold reduction). H5FS had relatively comparable infection rate as naïve mouse serum and therefore did not inhibit heterologous H1N1/H3N2 virus entry. Furthermore, H1N1-convalescent sera potentially increased H3N2 infection rate by 1.5-fold, which was not observed for our vaccine sera.
The competition of HA mini-stem immunized mice sera for binding to H1 HA (pdm Ca/09) was also determined using CR6261 immobilized on AR2G tips. The binding of H1 HA (pdm Ca/09) to CR6261 was probed in the absence and presence of different dilutions (as indicated) of HA mini-stem vaccinated mice sera.
Aby ułatwić początkującym akwarystom start z popularnym hobby, sera stworzyła specjalne oprogramowanie. Na nowej płycie CD zainteresowani znajdą porady z zakresu zakładania i pielęgnacji akwarium oraz propozycje i zalecenia dotyczące biotopu.
Użytkownik może ponadto zaprojektować swoje indywidualne akwarium według własnych życzeń. Rezultatem jest trójwymiarowy podgląd, jak i lista zakupów, za pomocą której będziesz mógł się zaopatrzyć w potrzebne produkty firmy sera w sklepie akwarystyczny24.
The use of ECISs for the detection of AGAs was first reported by Balkenhohl and Lisdat  . In order to get a suitable layer for binding high amounts of gliadins to gold electrodes, different layers for the modification of the electrode surface were investigated first. The degree of immobilization was determined by quartz crystal microbalance measurements. The results demonstrated that the polyelectrolyte polystyrene sulfonic acid (PSS) was the most effective surface modification for the binding of gliadins. After the binding of gliadins onto the modified gold electrode and the blocking of unspecific and residual binding sites with bovine serum albumin (BSA), the ready-to-use electrode was applied to the detection of AGAs. The electrode was incubated with standard solutions of AGAs from rabbit serum or human serum samples followed by a washing step. The antigen-antibody interaction was amplified by incubation with horseradish peroxidase (HRP)-labeled antibodies directed against rabbit IgG and human IgG, respectively. After a final washing step, the electrode was incubated in a solution of 3-amino-9-ethylcarbazole, the substrate for HRP. The precipitating product (3-azo-9-ethylcarbazole) enhanced the insulating properties of the electrode. Subsequently, the electrode was transferred to water and the reaction product analyzed by electrochemical impedance spectrometry in the presence of ferri/ferro-cyanide using a conventional three-electrode cell. The calibration of the AGA sensor was performed using different concentrations of five human sera, which had been characterized by conventional ELISA experiments before. A sigmoidal curve showed AGA concentrations in the range of 0.008 - 1.5 µmol/l.
In 1997, TG2 was identified as the CD-specific autoantigen  , which allowed the development of ELISA- based TGA tests, first using monkey esophagus or human umbilical cord tissue as antigen (EMA test) and then TG2 from guinea pig liver or human recombinant TG2 (TGA test)  . Similar to ECIS for AGA detection  (see Chapter 4), Balkenhohl and Lisdat developed an impedimetric immunosensor for TGA detection  . Screen- printed gold electrodes were layered with PSS and incubated with a solution of TG2 from guinea pig liver. Blocking, binding of serum antibodies and secondary labeled anti-IgA and anti-IgG antibodies, enzymatic reactions, and impedimetric measurements were the same as with the ECIS for AGA detection (see Chapter 4). A calibration curve was established by using different dilutions of a standard solution of TGAs from goat. Six different human sera, which had been characterized by a commercial ELISA kit (three positive and three negative), were analyzed for IgA and IgG TGAs by means of the developed ECIS. Both analytical tools showed significantly higher IgA and IgG TGA concentrations for CD patients in comparison to healthy individuals. However, quantitative differences between the values for the different sera, obtained either in the ELISA experiments or by ECIS analysis, were observed. This may have been due to less precise ECIS data in comparison to the ELISA.